ChiCTR2500111894 版本V1.0 版本创建时间2025/11/07 09:02:20 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2500111894 

最近更新日期:

Date of Last Refreshed on:

2025-11-07 09:01:48 

注册时间:

Date of Registration:

2025-11-07 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

先心患儿心肺康复方案

Public title:

Rehabilitation program for congenital heart disease patients

注册题目简写:

English Acronym:

研究课题的正式科学名称:

基于危重评分的先心术后患儿阶段性心肺康复方案的构建及应用

Scientific title:

Construction and Application of Stage-Based Cardiopulmonary Rehabilitation Program for Children after Congenital Heart Surgery Based on Critical Illness Score

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

金陈娣 

研究负责人:

金陈娣 

Applicant:

Chendi Jin 

Study leader:

Chendi Jin 

申请注册联系人电话:

Applicant telephone:

+86 571 8173 2466

研究负责人电话:

Study leader's telephone:

+86 571 8173 2466

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

154467055@qq.com

研究负责人电子邮件:

Study leader's E-mail:

154467055@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

浙江省杭州市滨江区滨盛路3333号

研究负责人通讯地址:

浙江省杭州市滨江区滨盛路3333号

Applicant address:

3333 Binsheng Road, Binjiang District, Hangzhou, Zhejiang

Study leader's address:

3333 Binsheng Road, Binjiang District, Hangzhou, Zhejiang

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

浙江大学医学院附属儿童医院

Applicant's institution:

Children's Hospital,Zhejiang University School of Medicine

研究负责人所在单位:

浙江大学医学院附属儿童医院

Affiliation of the Leader:

Children's Hospital,Zhejiang University School of Medicine

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2025-IRB-0352-P-01

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

浙江大学医学院附属儿童医院医学伦理委员会

Name of the ethic committee:

Ethics Committee of Children's Hospital,Zhejiang University School of Medicine

伦理委员会批准日期:

Date of approved by ethic committee:

2025-08-25 00:00:00

伦理委员会联系人:

漆林艳

Contact Name of the ethic committee:

Qi Linyan

伦理委员会联系地址:

浙江省杭州市滨江区滨盛路3333号

Contact Address of the ethic committee:

3333 Binsheng Road, Binjiang District, Hangzhou, Zhejiang

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 571 86670076

伦理委员会联系人邮箱:

Contact email of the ethic committee:

zuchiec@163.com

研究实施负责(组长)单位:

浙江大学医学院附属儿童医院

Primary sponsor:

Children's Hospital,Zhejiang University School of Medicine

研究实施负责(组长)单位地址:

浙江省杭州市滨江区滨盛路3333号

Primary sponsor's address:

3333 Binsheng Road, Binjiang District, Hangzhou, Zhejiang

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

浙江省

市(区县):

Country:

China

Province:

Zhejiang

City:

单位(医院):

浙江大学医学院附属儿童医院

具体地址:

浙江省杭州市滨江区滨盛路3333号

Institution
hospital:

Children's Hospital,Zhejiang University School of Medicine

Address:

3333 Binsheng Road, Binjiang District, Hangzhou, Zhejiang

经费或物资来源:

浙江省医药卫生科技计划

Source(s) of funding:

Zhejiang Provincial Medical and Health Science and Technology Plan

Target disease:

Cardiopulmonary rehabilitation therapy during postoperative intensive care for children with congenital heart disease.

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

非随机对照试验 

Study design:

Non randomized control 

研究目的:

本研究拟创建基于先心术后患儿实际危重程度评分为基础的阶段性的心肺联合康复方案,通过全面和规范的评定,采取分阶段综合医疗干预手段,促进先心患儿术后疾病恢复,改善心肺功能,提高远期生命质量。  

Objectives of Study:

This study aims to establish a phased cardiopulmonary rehabilitation program based on the actual criticality scores of children post-congenital heart surgery. Through comprehensive and standardized assessments, we will implement phased and comprehensive medical interventions to promote disease recovery in children post-congenital heart surgery, improve cardiopulmonary function, and enhance long-term quality of life.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.符合《小儿先天性心脏病诊治手册》中关于CHD诊断标准;行心脏手术;
2.术后入住ICU;
3.年龄≤14岁;
4.入住ICU时间>7天;

Inclusion criteria

1.Meet the diagnostic criteria for CHD as outlined in the "Handbook for the Diagnosis and Treatment of Congenital Heart Disease in Children"; 2.Admission to ICU after surgery; 3.Age <= 14 years old; 4. Staying in ICU for more than 7 days;

排除标准:

1.治疗期间死亡;
2.发生心率、血压不稳定,随时属于抢救状态;
3.合并有严重的心律失常;
4.合并有活动性出血;
5.处于高热状态(体温超过 38.5 ℃);
6.合并其它严重器质性疾病;
7.合并原发性哮喘等肺部疾病;
8.早产儿、低体重儿;

Exclusion criteria:

1.Died during treatment;
2.Unstable heart rate and blood pressure, requiring emergency treatment at any time;
3.Complicated with severe arrhythmia;
4.Complicated with active bleeding;
5.Being in a state of high fever (body temperature exceeding 38.5 ℃);
6.Comorbid with other severe organic diseases;
7.Combined with primary asthma and other pulmonary diseases;
8.Premature infants and low-birth-weight infants;

研究实施时间:

Study execute time:

From 2024-01-01 00:00:00 To 2026-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2026-01-01 00:00:00 To 2026-06-30 00:00:00  

干预措施:

Interventions:

组别:

对照组

样本量:

30

Group:

Control group

Sample size:

干预措施:

传统康复管理方案

干预措施代码:

Intervention:

Traditional rehabilitation management plan

Intervention code:

组别:

试验组

样本量:

30

Group:

Test group

Sample size:

干预措施:

基于危重评分的先心患儿术后阶段性心肺康复方案

干预措施代码:

Intervention:

Postoperative staged cardiopulmonary rehabilitation program for children with congenital heart disease based on critical care scoring

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

浙江省 

市(区县):

 

Country:

China 

Province:

Zhejiang 

City:

 

单位(医院):

浙江大学医学院附属儿童医院 

单位级别:

三级甲等 

Institution
hospital:

Children's Hospital,Zhejiang University School of Medicine

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

肺功能

指标类型:

主要指标

Outcome:

Pulmonary function

Type:

Primary indicator

测量时间点:

心脏重症监护中心

测量方法:

心肺康复小组成员对患儿从康复干预前、干预第3天、第7天以及转出ICU时进行资料收集

Measure time point of outcome:

Cardiac Intensive Care Unit

Measure method:

Members of the cardiopulmonary rehabilitation team collected data from pediatric patients before rehabilitation intervention, on the third day of intervention, on the seventh day of intervention, and upon transfer out of the ICU

指标中文名:

徒手肌力测定

指标类型:

次要指标

Outcome:

Manual muscle testing

Type:

Secondary indicator

测量时间点:

心脏重症监护中心

测量方法:

心肺康复小组成员对患儿从康复干预前、干预第3天、第7天以及转出ICU时进行资料收集

Measure time point of outcome:

Cardiac Intensive Care Unit

Measure method:

Members of the cardiopulmonary rehabilitation team collected data from pediatric patients before rehabilitation intervention, on the third day of intervention, on the seventh day of intervention, and upon transfer out of the ICU

指标中文名:

心功能检查指标

指标类型:

主要指标

Outcome:

Cardiac function examination indicators

Type:

Primary indicator

测量时间点:

心脏重症监护中心

测量方法:

心肺康复小组成员对患儿从康复干预前、干预第3天、第7天以及转出ICU时进行资料收集

Measure time point of outcome:

Cardiac Intensive Care Unit

Measure method:

Members of the cardiopulmonary rehabilitation team collected data from pediatric patients before rehabilitation intervention, on the third day of intervention, on the seventh day of intervention, and upon transfer out of the ICU

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

NA

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 0 years
最大 Max age 14 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

None

是否共享原始数据:

IPD sharing

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Nothing

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表,数据采集和电子采集

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case record sheet, data collection, and electronic data collection

数据与安全监察委员会:

Data and Safety Monitoring Committee:

无/No

注册人:

Name of Registration:

 2025-11-07 09:01:48